Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trials Post author: Post published:December 5, 2023 Post category:uncategorized The safety, efficacy, and immunogenicity of a mRNA-based vaccine. You Might Also Like Soft magnetic muscles power innovative origami robots for biomedical use October 21, 2025 ALKBH3 regulates glycolysis and doxorubicin resistance in triple negative breast cancer July 12, 2025 Beyond PMS: A poorly understood disorder means periods of despair for some women July 3, 2024
ALKBH3 regulates glycolysis and doxorubicin resistance in triple negative breast cancer July 12, 2025